Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07661758
PHASE3

Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

This prospective randomized controlled multicenter study will be conducted to evaluate the effects of pre-emptive IV lidocaine dose on the incidence and severity of intraoperative headache that may occur after the extra-abdominal manual uterine fundal pressure in patients undergoing cesarean section under spinal anesthesia.

Official title: Pre-emptive Single Intravenous Lidocaine Dose to Prevent Post-Fundal Pressure Headache During Cesarean Section: The LID-HEAD Multi-center Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

680

Start Date

2026-07-01

Completion Date

2026-11-02

Last Updated

2026-07-06

Healthy Volunteers

No

Interventions

DRUG

Lidocaine IV

IV lidocaine 1.5 mg/kg (diluted with 0.9% isotonic saline to a total volume of 10 ml) over 5 minutes with the start of skin incision after ensuring negative baseline headache.

OTHER

Saline 0.9%

IV 10 ml isotonic saline over 5 minutes with the start of skin incision after ensuring negative baseline headache.

Locations (1)

Tanta University Hospitals

Tanta, Gharbia Governorate, Egypt